Atomwise is a company that is revolutionizing the field of drug discovery by using artificial intelligence (AI) to develop small molecule drugs. The company’s approach is based on the idea that traditional drug discovery methods are time-consuming and expensive, and that AI can help to streamline the process and make it more efficient.
Atomwise’s technology is based on deep learning algorithms that are trained on large datasets of molecular structures and their associated properties. The algorithms are able to analyze the data and identify patterns that can be used to predict the properties of new molecules.